glp-1 agonists gastrointestinal side effects constipation diarrhea Managing GLP-1/GIP with diet and lifestyle Recommendations for managing gastrointestinal side

Meanwhile, individuals who took a high-potency GLP-1 drug approved for obesity - such as semaglutide - had greater persistence at 14% three years after initiating therapy

doi: 10.1093/eurheartj/ehz486 6 American Diabetes A

The campaign is particularly important for communities of color and other populations that often face barriers to accessing specialty care and safe medications

GLP-1 can promote intracellular cholesterol outflow, reduce intracellular cholesterol content, and maintain intracellular cholesterol homeostasis through the ABCA1 pathway

One recently recognized condition, known as non-arteritic anterior ischemic optic neuropathy (NAION), has been associated with a very small number of users and can affect vision

2019 ESC guidelines on diabetes, prediabetes, and cardiovascular diseases developed in collaboration with the EASD